Bortezomib Injection
- Product: Generic
- Presentation: Lyophilized Powder for Injection
- Strengths: 1 mg, 2 mg, 3.5 mg per vial (15 & 30 units packaging)
We are a reputable supplier of Bortezomib Injection, which is used to treat multiple myeloma and mantle cell lymphoma. We offer 1 mg, 2 mg, and 3.5 mg vials in bulk packaging of 15 units and 30 units with OEM/private labeling and complete export documentation.
Description
Bortezomib is a reversible inhibitor of the proteasome that interferes with protein degradation in cancer cells, causing cell death by apoptosis. It is both an induction and relapsed treatment for multiple myeloma and also employed in mantle cell lymphoma.
It is either given intravenously (IV) or subcutaneously (SC) by cancer professionals.
Uses of Bortezomib Injection
- Multiple Myeloma (first-line and relapsed cases)
- Mantle Cell Lymphoma (MCL)
We supply oncology hospitals, government tenders, cancer care centers, and global distributors across Asia, Africa, Middle East.
Q1. What is Bortezomib Injection used for?
A: It is mainly administered in the treatment of mantle cell lymphoma and multiple myeloma.
Q2. What are the types of strengths and packaging?
A: Bortezomib is provided in 1 mg, 2 mg, and 3.5 mg vials, which are packed in 15-unit or 30-unit bulk packing.
Q3. How is it given?
A: Under medical supervision, by IV (intravenous) or SC (subcutaneous) injection.
Q4. Do you offer OEM/private labeling?
A: Yes, we offer neutral packaging and OEM/private labeling for international distributors.
Q5. Do your products carry export certification?
A: Yes, they all originate in plants that are ISO/WHO-GMP-certified and have full export documentation.
You may also be interested Bleomycin Injection 100 mg– a powerful option for resistant infections.
